U.S. Stocks Move｜Novo Nordisk drops 3% pre-market after cutting semaglutide prices in the U.S. by 50%
Show original
Gelonghui, February 24th | Novo Nordisk fell 3% in pre-market trading, while Eli Lilly dropped 4%. According to reports, Novo Nordisk has reduced the price of semaglutide (Wegovy®) in the US by 50%, to $675 per month.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Federal Reserve Governor Quarles: AI Investment Craze Could Boost Neutral Rate in Near Term
BlockBeats•2026/02/24 14:35
Bank of England Governor Bailey discusses room for monetary policy easing
AIcoin•2026/02/24 14:28
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$63,013.38
-4.69%
Ethereum
ETH
$1,808.51
-5.68%
Tether USDt
USDT
$0.9998
-0.01%
XRP
XRP
$1.32
-4.45%
BNB
BNB
$579.46
-4.98%
USDC
USDC
$1
-0.02%
Solana
SOL
$76.3
-5.00%
TRON
TRX
$0.2802
-1.65%
Dogecoin
DOGE
$0.09062
-5.90%
Bitcoin Cash
BCH
$478.22
-9.98%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now